Delaware | 0-24274 | 33-0361285 | ||
(State or other jurisdiction | (Commission | (IRS Employer | ||
of incorporation) | File Number) | Identification No.) |
6455 Nancy Ridge Drive, San Diego, California | 92121 | |
(Address of principal executive offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition. | ||||||||
9.01 Financial Statements and Exhibits. | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Item 2.02 | Results of Operations and Financial Condition. |
9.01 | Financial Statements and Exhibits. |
Exhibit | ||
Number | Description of Exhibit | |
99.1 | Press Release (furnished pursuant to Item 2.02 of Form 8-K) |
La Jolla Pharmaceutical Company |
||||
Date: February 28, 2008 | By: | /s/ Gail A. Sloan | ||
Gail A. Sloan | ||||
Vice President of Finance and Secretary | ||||